Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 6/20 | 0.49 |
| ▸ | TACR2 | P21452 | 5/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.45 |
| ▸ | KCNK3 | O14649 | 12/20 | 0.42 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1717592 | 0.99 | TACR3 (0.48) | TACR3TACR2OPRM1KCNK3TRPV4 | |
| SCHEMBL1717606 | 0.93 | GAA (0.49) | TACR3TACR2OPRM1KCNK3ALDH1A1 | |
| SCHEMBL1717394 | 0.93 | TACR3 (0.54) | TACR3TACR2OPRM1KCNK3 | |
| SCHEMBL1717925 | 0.92 | TACR3 (0.49) | TACR3TACR2OPRM1KCNK3TRPV4 | |
| SCHEMBL1718258 | 0.92 | TACR3 (0.53) | TACR3TACR2OPRM1KCNK3 | |
| SCHEMBL1717248 | 0.91 | TACR3 (0.49) | TACR3TACR2OPRM1KCNK3TRPV4 | |
| SCHEMBL1717467 | 0.91 | TACR3 (0.42) | TACR3TACR2OPRM1KCNK3ALDH1A1 | |
| SCHEMBL1717938 | 0.91 | TACR3 (0.48) | TACR3TACR2OPRM1KCNK3TRPV4 | |
| SCHEMBL1719009 | 0.91 | TACR3 (0.47) | TACR3TACR2OPRM1KCNK3TRPV4 | |
| SCHEMBL1724094 | 0.90 | TACR3 (0.44) | TACR3TACR2OPRM1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2150534-B1 | ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS | LUNDBECK & CO AS H (DK) | 2012-01-11 | — | — | EP | claimed |
| EP-2150534-B1 | ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS | LUNDBECK & CO AS H (DK) | 2012-01-11 | — | — | EP | disclosed |